GABRIEL
ZUBILLAGA GARMENDIA
Investigador/a en el periodo 1990-2016
Hospital Arnau de Vilanova
Valencia, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Arnau de Vilanova (2)
2016
-
Factors associated with fatality during the intensive phase of anti-tuberculosis treatment
PLoS ONE, Vol. 11, Núm. 8
2006
-
Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 3, pp. 536-545